EUVIMEDEUVIMED entdecken
Open Access · CC BY 3.0

Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response

Derek Grose iD, Graham Devereux, Louise Brown, Richard Jones iD, Dave Sharma, Colin Selby, David S Morrison, Kirsty Docherty iD, David McIntosh iD, Penny McElhinney, Marianne Nicolson, Donald C McMillan und 1 weitere

Lung Cancer International · 2014

DOI: 10.1155/2014/731925 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Lung Cancer International, 2014. Verfasst von Derek Grose und 12 weiteren Autor:innen. Beteiligte Einrichtung: Beatson Oncology Centre, 1053 Great Western Road, Glasgow G12 0YN, UK. Die Arbeit wurde bisher 4-mal zitiert (Crossref) und nennt 31 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 3.0). Gefördert von: West of Scotland Lung Cancer Group.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Prediction of survival in patients diagnosed with lung cancer remains problematical. The aim of the present study was to examine the clinical utility of an established objective marker of the systemic inflammatory response, the Glasgow Prognostic Score, as the basis of risk stratification in patients with lung cancer.

Methods

Between 2005 and 2008 all newly diagnosed lung cancer patients coming through the multidisciplinary meetings (MDTs) of four Scottish centres were included in the study. The details of 882 patients with a confirmed new diagnosis of any subtype or stage of lung cancer were collected prospectively.

Results

The median survival was 5.6 months (IQR 4.8–6.5). Survival analysis was undertaken in three separate groups based on mGPS score. In the mGPS 0 group the most highly predictive factors were performance status, weight loss, stage of NSCLC, and palliative treatment offered. In the mGPS 1 group performance status, stage of NSCLC, and radical treatment offered were significant. In the mGPS 2 group only performance status and weight loss were statistically significant.

Discussion

This present study confirms previous work supporting the use of mGPS in predicting cancer survival; however, it goes further by showing how it might be used to provide more objective risk stratification in patients diagnosed with lung cancer.

Autor:innen und Institutionen

  • Beatson Oncology Centre, 1053 Great Western Road, Glasgow G12 0YN, UK.
  • University of Aberdeen, Aberdeen, UK.
  • Inverclyde Royal Hospital, Inverclyde, UK.
  • Queen Margaret Hospital, Dunfermline, UK.
  • University of Glasgow, Glasgow, UK.
  • Glasgow Royal Infirmary, Glasgow, UK.

ORCID-Profile: Derek Grose, Richard Jones, Kirsty Docherty, David McIntosh

Förderung

  • West of Scotland Lung Cancer Group

Zitieren

APA

Grose, D., Devereux, G., Brown, L., Jones, R., Sharma, D., Selby, C., Morrison, D. S., Docherty, K., McIntosh, D., McElhinney, P., Nicolson, M., McMillan, D. C., & Milroy, R. (2014). Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response. Lung Cancer International. https://doi.org/10.1155/2014/731925

Vancouver

Grose D, Devereux G, Brown L, Jones R, Sharma D, Selby C, et al. Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response. Lung Cancer International. 2014. doi:10.1155/2014/731925

BibTeX
@article{Grose2014,
  author = {Grose, Derek and Devereux, Graham and Brown, Louise and Jones, Richard and Sharma, Dave and Selby, Colin and Morrison, David S and Docherty, Kirsty and McIntosh, David and McElhinney, Penny and Nicolson, Marianne and McMillan, Donald C and Milroy, Robert},
  title = {Simple and Objective Prediction of Survival in Patients with Lung Cancer: Staging the Host Systemic Inflammatory Response},
  journal = {Lung Cancer International},
  year = {2014},
  doi = {10.1155/2014/731925}
}
Kostenlos starten →